For the coprimary outcomes , the intervention was associated with improved overall risk factor measurements ( 62.8 % versus 53.4 % risk ratio ; 1.25 ; 95 % confidence interval , 1.04-1 .50 ; P = 0.02 ) , but there was no significant differences in recommended prescriptions for the high-risk cohort ( n = 10,308 ; 56.8 % versus 51.2 % ; P = 0.12 ) .